Cargando…

Ampullary Cancer: Histological Subtypes, Markers, and Clinical Behaviour—State of the Art and Perspectives

There are different cancers in the peri-ampullary region, including pancreatic ductal adenocarcinoma (PDAC), duodenum cancers (DCs), and ampullary adenocarcinoma (AAC). Here, significant morphological–molecular characterizations should be necessary for the distinction of primary tumours and classifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nappo, Gennaro, Funel, Niccola, Laurenti, Virginia, Stenner, Elisabetta, Carrara, Silvia, Bozzarelli, Silvia, Spaggiari, Paola, Zerbi, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378042/
https://www.ncbi.nlm.nih.gov/pubmed/37504367
http://dx.doi.org/10.3390/curroncol30070507
_version_ 1785079667785465856
author Nappo, Gennaro
Funel, Niccola
Laurenti, Virginia
Stenner, Elisabetta
Carrara, Silvia
Bozzarelli, Silvia
Spaggiari, Paola
Zerbi, Alessandro
author_facet Nappo, Gennaro
Funel, Niccola
Laurenti, Virginia
Stenner, Elisabetta
Carrara, Silvia
Bozzarelli, Silvia
Spaggiari, Paola
Zerbi, Alessandro
author_sort Nappo, Gennaro
collection PubMed
description There are different cancers in the peri-ampullary region, including pancreatic ductal adenocarcinoma (PDAC), duodenum cancers (DCs), and ampullary adenocarcinoma (AAC). Here, significant morphological–molecular characterizations should be necessary for the distinction of primary tumours and classifications of their subtypes of cancers. The sub classification of AACs might include up to five different variants, according to different points of view, concerning the prevalence of the two more-cellular components found in the ampulla. In particular, regarding the AACs, the most important subtypes are represented by the intestinal (INT) and the pancreato-biliary (PB) ones. The subtyping of AACs is essential for diagnosis, and their identifications have been impacting clinical management responses to treatments and overall survival (os) after surgery. Pb is associated with a worse clinical outcome. Otherwise, the criteria, through which are possible to attribute its subtype classification, are not well established. A triage of immune markers represented by CK7, CK20, and CDX-2 seem to represent the best compromise in order to split the cohort of AAC patients in the INT and PB groups. The test of choice for the sub-classification of AACs is represented by the immuno-histochemical approach, in which its molecular classification acquires its diagnostic, predictive, and prognostic value for both the INT and PB patients.
format Online
Article
Text
id pubmed-10378042
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103780422023-07-29 Ampullary Cancer: Histological Subtypes, Markers, and Clinical Behaviour—State of the Art and Perspectives Nappo, Gennaro Funel, Niccola Laurenti, Virginia Stenner, Elisabetta Carrara, Silvia Bozzarelli, Silvia Spaggiari, Paola Zerbi, Alessandro Curr Oncol Review There are different cancers in the peri-ampullary region, including pancreatic ductal adenocarcinoma (PDAC), duodenum cancers (DCs), and ampullary adenocarcinoma (AAC). Here, significant morphological–molecular characterizations should be necessary for the distinction of primary tumours and classifications of their subtypes of cancers. The sub classification of AACs might include up to five different variants, according to different points of view, concerning the prevalence of the two more-cellular components found in the ampulla. In particular, regarding the AACs, the most important subtypes are represented by the intestinal (INT) and the pancreato-biliary (PB) ones. The subtyping of AACs is essential for diagnosis, and their identifications have been impacting clinical management responses to treatments and overall survival (os) after surgery. Pb is associated with a worse clinical outcome. Otherwise, the criteria, through which are possible to attribute its subtype classification, are not well established. A triage of immune markers represented by CK7, CK20, and CDX-2 seem to represent the best compromise in order to split the cohort of AAC patients in the INT and PB groups. The test of choice for the sub-classification of AACs is represented by the immuno-histochemical approach, in which its molecular classification acquires its diagnostic, predictive, and prognostic value for both the INT and PB patients. MDPI 2023-07-22 /pmc/articles/PMC10378042/ /pubmed/37504367 http://dx.doi.org/10.3390/curroncol30070507 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Nappo, Gennaro
Funel, Niccola
Laurenti, Virginia
Stenner, Elisabetta
Carrara, Silvia
Bozzarelli, Silvia
Spaggiari, Paola
Zerbi, Alessandro
Ampullary Cancer: Histological Subtypes, Markers, and Clinical Behaviour—State of the Art and Perspectives
title Ampullary Cancer: Histological Subtypes, Markers, and Clinical Behaviour—State of the Art and Perspectives
title_full Ampullary Cancer: Histological Subtypes, Markers, and Clinical Behaviour—State of the Art and Perspectives
title_fullStr Ampullary Cancer: Histological Subtypes, Markers, and Clinical Behaviour—State of the Art and Perspectives
title_full_unstemmed Ampullary Cancer: Histological Subtypes, Markers, and Clinical Behaviour—State of the Art and Perspectives
title_short Ampullary Cancer: Histological Subtypes, Markers, and Clinical Behaviour—State of the Art and Perspectives
title_sort ampullary cancer: histological subtypes, markers, and clinical behaviour—state of the art and perspectives
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378042/
https://www.ncbi.nlm.nih.gov/pubmed/37504367
http://dx.doi.org/10.3390/curroncol30070507
work_keys_str_mv AT nappogennaro ampullarycancerhistologicalsubtypesmarkersandclinicalbehaviourstateoftheartandperspectives
AT funelniccola ampullarycancerhistologicalsubtypesmarkersandclinicalbehaviourstateoftheartandperspectives
AT laurentivirginia ampullarycancerhistologicalsubtypesmarkersandclinicalbehaviourstateoftheartandperspectives
AT stennerelisabetta ampullarycancerhistologicalsubtypesmarkersandclinicalbehaviourstateoftheartandperspectives
AT carrarasilvia ampullarycancerhistologicalsubtypesmarkersandclinicalbehaviourstateoftheartandperspectives
AT bozzarellisilvia ampullarycancerhistologicalsubtypesmarkersandclinicalbehaviourstateoftheartandperspectives
AT spaggiaripaola ampullarycancerhistologicalsubtypesmarkersandclinicalbehaviourstateoftheartandperspectives
AT zerbialessandro ampullarycancerhistologicalsubtypesmarkersandclinicalbehaviourstateoftheartandperspectives